Skip to main content

Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway

The Original Article was published on 04 October 2021

Correction to: Nano Convergence (2021) 8:29

https://doi.org/10.1186/s40580-021-00279-2

Following publication of the original article [1], the author identified the errors in the Figures, Supplementary Material and Availability of data and materials. The corrected Figs. 7A, 9A, B and Fig. S3 presented with this correction.

Fig. 7
figure 1

Hyperthermia inhibits HCC migration and invasion in vitro and in vivo. A Representative images of migration assays for HCC cells in diferent groups. B Representative images of invasion assays for HCC cells. C E-cadherin, N-cadherin, Vimentin and ZEB2 expression evaluated by western blotting in HCC cells. D Holistic view and H&E staining of excised lungs from a mouse model of metastasis. Representative images of lung tissues were shown in the left panel. Arrows indicate the location of metastatic lung foci. Corresponding H&E staining of metastatic lung foci were shown in the right panel. The scale bar=100 μm. E Incidence of metastatic lung nodules of each group. **p<0.01

Fig. 9
figure 2

Mechanistic analysis of PTT with PPCu. A H&E, ki67, MT-CO1 and TUNEL staining of tumor regions in every group. Scale bar=100 μm. B H&E staining of heart, liver, spleen, lung and kidney collected from diferent groups of mice at the 14th day after diferent treatments

Data availability

All datasets and materials used during the current study are available from the corresponding author on reasonable request.

Reference

  1. Dong, T., Jiang, J., Zhang, H. et al. PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway. Nano Convergence 8, 29 (2021).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s40580-021-00279-2.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, T., Jiang, J., Zhang, H. et al. Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway. Nano Convergence 11, 37 (2024). https://doi.org/10.1186/s40580-024-00444-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40580-024-00444-3